Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
UBA3 (Ubiquitin-like modifier activating enzyme 3) is the catalytic subunit of the NEDD8-activating enzyme E1, a dimeric enzyme complex (with APPBP1/NAE1 as the regulatory subunit) responsible for activating NEDD8, a ubiquitin-like modifier that regulates protein degradation and protein homeostasis[1][3][4][6]. UBA3 catalyzes the first critical step in the *neddylation* cascade, which is essential for proper function of cullin-RING E3 ubiquitin ligases (CRLs) and, consequently, cell cycle regulation, signal transduction, and embryogenesis[6]. UBA3-mediated neddylation modifies protein activity, localization, and stability, and dysregulation is implicated in cancer and potentially other diseases. The critical nature of this pathway makes UBA3 a promising anti-cancer drug target, with small-molecule inhibitors (such as pevonedistat/MLN4924) in clinical studies[6]. Inhibition of UBA3 leads to suppression of cullin-RING ligase activity, resulting in cell cycle arrest and apoptosis, though safety concerns exist due to its fundamental roles in normal cellular physiology.
Inhibition of enzymatic activity (neddylation blockade), suppression of cullin-RING ligase activation, cell cycle arrest, apoptosis induction
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ubiquitin-like modifier activating enzyme 3 (UBA3).